OTHER LIPID MODIFYING AGENTS IN ATC
- alirocumab (PRALUENT)
- bempedoic acid (NILEMDO)
- evinacumab (EVKEEZA)
- evolocumab (REPATHA)
- ezetimibe (AURO-EZETIMIBE, SPC-EZETIMIBE, MINT-EZETIMIBE, M-EZETIMIBE, SANDOZ EZETIMIBE, NRA-EZETIMIBE TABLETS, JAMP-EZETIMIBE, PMS-EZETIMIBE, MAR-EZETIMIBE, TEVA-EZETIMIBE, EZETIMIBE, ACH-EZETIMIBE, EZETROL, AG-EZETIMIBE, BIO-EZETIMIBE)
- icosapent ethyl (VASCEPA)
- inclisiran (inclisiran sodium) (LEQVIO)
- lomitapide (lomitapide mesylate) (JUXTAPID)
- olezarsen (olezarsen sodium) (TRYNGOLZA)
- plozasiran (plozasiran sodium) (REDEMPLO)
Using Health Canada Drug Database
updated on 06Aug2026.